The Technical Analyst
Select Language :

Kindred Biosciences Inc [KIN]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals

Kindred Biosciences Inc is listed at the NASDAQ Exchange

0.11% $9.25

Last updated: 28 Nov 2021 @ 18:17 pm


FUNDAMENTALS
MarketCap: 420.53 mill
EPS: -1.018
P/E: 0.000
Earnings Date: Aug 05, 2021
SharesOutstanding: 45.46 mill
Avg Daily Volume: 1.506 mill
RATING 2021-08-30
B+
Neutral
RATING DETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
1/202/203/204/201/212/21
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0.000 | sector: PE 371.73
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE 0.000 | industry: PE 30.15
DISCOUNTED CASH FLOW VALUE
$9.55
(3.20%) $0.296
Date: 2021-11-28

Insider Trading

Date Person Action Amount type
2021-08-27 Montgomery Herbert D Sell 27 500 Stock Option (right to buy)
2021-08-27 Mccracken Joseph S Sell 41 890 Stock Option (right to buy)
2021-08-27 Lien Lyndon Sell 47 000 Stock Option (right to buy)
2021-08-27 Liu Nanxi Sell 48 000 Stock Option (right to buy)
2021-08-27 Elanco Animal Health Inc Buy 45 508 938 Common Stock, par value $0.0001
INSIDER POWER
76.76
Last 100 transactions
Buy: 46 753 803 | Sell: 4 555 064

Forecast: 14:40 - $9.25

Live Trading Signals (every 1 min)

Forecast 1: 13:10 - $9.25
Forecast 2: 14:00 - $9.25
Forecast 3: 14:40 - $9.25
SCORE
-5.30
Sell
Score Algorithm Version: 0.9M
Last version updated: Thurs 28th Oct 2021
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $9.25 (0.11% )
Volume 0.178 mill
Avg. Vol. 1.506 mill
% of Avg. Vol 11.86 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Kindred Biosciences Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Kindred Biosciences Inc

RSI

Intraday RSI14 chart for Kindred Biosciences Inc
The Live Chart for Kindred Biosciences Inc
Profile picture for
            Kindred Biosciences Inc

KIN

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.

Last 10 Buy Signals
Date Signal @
DOGEUSDNov 28 - 13:12$0.196
XRPUSDNov 28 - 12:590.914
BTCUSDNov 28 - 12:3054 098
XRPUSDNov 28 - 12:260.920
XRPUSDNov 28 - 12:230.921
XRPUSDNov 28 - 12:190.922
BTCUSDNov 28 - 12:1654 220
XRPUSDNov 28 - 12:130.923
BTCUSDNov 28 - 12:1054 267
BTCUSDNov 28 - 12:0454 208

Stock Peers

Company Price Change
KIN9.250.11%
ADMA1.450-3.33%
BIVI6.141.49%
CDMOP25.060.04%
CMMB8.87-0.22%
CNTG6.91-4.03%
CRBP0.884-3.06%
CTIC2.485.98%
LRMR10.12-3.89%
OBSV2.240.00%
ORPH3.30-2.94%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.